Cargando…
An efficient feeder-free and chemically-defined expansion strategy for highly purified natural killer cells derived from human cord blood
INTRODUCTION: Natural killer cells (NKCs) are immune cells that can attack cancer cells through the direct recognition of ligands without prior sensitization. Cord blood-derived NKCs (CBNKCs) represent a promising tool for allogenic NKC-based cancer immunotherapy. Efficient NKC expansion and decreas...
Autores principales: | Nakazawa, Tsutomu, Maeoka, Ryosuke, Morimoto, Takayuki, Matsuda, Ryosuke, Nakamura, Mitsutoshi, Nishimura, Fumihiko, Yamada, Shuichi, Nakagawa, Ichiro, Park, Young-Soo, Ito, Toshihiro, Nakase, Hiroyuki, Tsujimura, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247952/ https://www.ncbi.nlm.nih.gov/pubmed/37303464 http://dx.doi.org/10.1016/j.reth.2023.05.006 |
Ejemplares similares
-
Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors
por: Nakazawa, Tsutomu, et al.
Publicado: (2022) -
CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma
por: Nakazawa, Tsutomu, et al.
Publicado: (2023) -
Therapeutic Anti-KIR Antibody of 1–7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthotopic Tumors Derived Therefrom
por: Maeoka, Ryosuke, et al.
Publicado: (2023) -
Natural Killer Cell-Based Immunotherapy against Glioblastoma
por: Morimoto, Takayuki, et al.
Publicado: (2023) -
Ex Vivo Expanded and Activated Natural Killer Cells Prolong the Overall Survival of Mice with Glioblastoma-like Cell-Derived Tumors
por: Shida, Yoichi, et al.
Publicado: (2021)